ClinicalTrials.gg
Active, not recruitingNCT06913972Updated Apr 6, 2025

A Comparative Analysis of Myopia Prevalence Among Madarsa Students vs. Non-Madarsa Students in Sukkur

An observational study in Myopia, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 5 Years to 20 Years. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Superior University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
364
Ages
5 Years to 20 Years
Sex
All
01

Study summary

Myopia (nearsightedness) has become a major global health concern, particularly among students, due to factors such as prolonged screen time, close-up work, and limited outdoor activities. In regions like Sukkur, Pakistan, the educational environments and lifestyles of students in Madarsas (religious schools) differ significantly from those in non-Madarsa (regular) schools, potentially influencing the prevalence of myopia. This comparative cross-sectional study aims to assess and compare the prevalence of myopia among Madarsa and non-Madarsa students in Sukkur.

Read the detailed description

The study will be conducted at Al Shifa Trust Eye Hospital over six months, involving students aged 5-20 years. Informed consent will be obtained from parents or guardians, and a structured questionnaire will collect data on lifestyle factors such as time spent on near work, outdoor activities, family history of refractive errors, and the use of corrective eyewear. Visual acuity and refractive errors will be assessed using standard eye charts, cycloplegic refraction, and measurements of keratometry, biometry, and axial length. The data will be analyzed using descriptive statistics, including frequencies, means, and standard deviations, with normality tests applied to continuous variables. Chi-square tests and Independent t-tests will be used for comparative analysis, while logistic regression will assess risk factors associated with myopia. The study will help determine the prevalence of myopia and its contributing factors in these student populations, informing potential interventions.

02

Conditions studied

  • Myopia

Browse trials for

03

In context

Myopia

1,007 studies on the registry are indexed under Myopia; 210 are open to participants now.

This study's enrollment of 364 is above the median of 150 across 176 observational studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Superior University is the lead sponsor of 253 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

To compare the prevalence of myopia among Madarsaand schoolstudents in Sukkur.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students aged 5-20 years.[18]
  • Students of Sukkur enrolled in either Madarsa or schools.
  • Parents or guardians who understand and sign the informed consent form.
  • Students who are willing to undergo an eye examination and complete the research

Exclusion criteria

Exclusion Criteria:

  • Students with known systemic diseases or eye conditions (e.g., cataracts, retinal diseases) that could influence the assessment of myopia.
  • Students who have had corrective eye surgery (e.g., LASIK) or those who have worn contact lenses or glasses for less than 3 months.
  • Students unable to participate due to language barriers or other communincation difficulties
  • Students with neurological conditions affecting vision
  • Students unable to cooperate with visual acuity testing due to cognitive impairments"
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
364 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. refraction

    In the eye, refraction is the bending of light rays as they pass through the cornea and lens, focusing them onto the retina for clear vision

    Time frame: 12 Months

  2. auto-refractometer

    An auto-refractometer is a device used in eye exams to objectively measure a person's refractive error and determine the prescription needed for glasses or contact lenses, by analyzing how light reflects off the eye

    Time frame: 12 Months

07

Study locations

1 site
  • Al Shifa trust eye Hospital
    Sukkur, Sindh, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06913972
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Apr 6, 2025
Start date
Mar 20, 2025
Primary completion
Jun 20, 2025 (estimated)
Completion
Feb 20, 2026 (estimated)
Last update
Apr 6, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion